TipRanks
Alpa Laboratories Limited (IN:ALPA)
:ALPA
India Market
Want to see IN:ALPA full AI Analyst Report?

Alpa Laboratories Limited (ALPA) Price & Analysis

3 Followers

ALPA Stock Chart & Stats

₹75.60
-₹1.63(-1.24%)
At close: 4:00 PM EST
₹75.60
-₹1.63(-1.24%)

Bulls Say, Bears Say

Bulls Say
Conservative Balance SheetVery low leverage gives Alpa financial resilience and reduces the burden of interest and refinancing obligations. This conservative funding structure preserves flexibility to support operations or asset growth while making the business better positioned to withstand periods of weaker profitability.
Growing Equity BaseThe steadily expanding equity base indicates accumulated retained earnings and supports a stronger capital foundation for the pharmaceutical business. Combined with reported industry-context returns on equity of roughly 8% in 2026, it provides evidence of ongoing internal capital formation despite recent pressure.
Positive Operating Cash FlowPositive operating cash flow and renewed free cash flow in 2026 show that Alpa can generate cash from its operations over time. Although conversion is weak, the 2026 improvement provides some funding capacity for working capital and investment without relying heavily on debt.
Bears Say
Revenue ContractionThe latest revenue decline, following uneven growth across prior years, indicates that demand expansion is not yet consistent. For a finished-medicines manufacturer, this weakens visibility into future scale and makes it harder to sustain operating leverage or plan capacity and investment confidently.
Severe Margin CompressionThe sharp reduction in gross and operating margins materially weakens the earnings power of the core business. An EBIT margin near 1.1% leaves limited protection against further cost or pricing pressure, reducing the sustainability of profits even if revenue stabilizes.
Weak Cash ConversionLow operating-cash conversion suggests reported earnings are not translating efficiently into cash, while prior negative free cash flow highlights uneven funding needs. This reduces earnings quality and predictability, potentially limiting internally funded growth despite the strong balance sheet.

ALPA FAQ

What was Alpa Laboratories Limited’s price range in the past 12 months?
Alpa Laboratories Limited lowest stock price was ₹46.00 and its highest was ₹99.75 in the past 12 months.
    What is Alpa Laboratories Limited’s market cap?
    Alpa Laboratories Limited’s market cap is ₹1.26B.
      When is Alpa Laboratories Limited’s upcoming earnings report date?
      Alpa Laboratories Limited’s upcoming earnings report date is Nov 12, 2026 which is in 38 days.
        How were Alpa Laboratories Limited’s earnings last quarter?
        Alpa Laboratories Limited released its earnings results on Aug 13, 2026. The company reported ₹0.466 earnings per share for the quarter.
          Is Alpa Laboratories Limited overvalued?
          According to Wall Street analysts Alpa Laboratories Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Alpa Laboratories Limited pay dividends?
            Alpa Laboratories Limited does not currently pay dividends.
            What is Alpa Laboratories Limited’s EPS estimate?
            Alpa Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Alpa Laboratories Limited have?
            Alpa Laboratories Limited has 21,040,600 shares outstanding.
              What happened to Alpa Laboratories Limited’s price movement after its last earnings report?
              Alpa Laboratories Limited reported an EPS of ₹0.466 in its last earnings report. Following the earnings report the stock price went down -0.537%.
                Which hedge fund is a major shareholder of Alpa Laboratories Limited?
                Currently, no hedge funds are holding shares in IN:ALPA
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Alpa Laboratories Limited

                  Established in Indore, India in 1967, Alpa Laboratories Limited focuses on the manufacturing, marketing, and distribution of finished pharmaceutical products, both domestically within India and for export. The company offers a wide array of human-grade medications, encompassing ethical, generic, and over-the-counter varieties, available in diverse forms such as injections, tablets, capsules, eye and ear drops, ointments, creams, and gels. Furthermore, it supplies veterinary pharmaceuticals, including boluses, injections, and intra-mammary infusions. Its extensive product range addresses numerous therapeutic categories, including anti-infectives (covering antibacterials, antibiotics, antifungals, antiprotozoals, and antivirals), pain relievers, anti-inflammatory drugs, cold and cough remedies, cardiovascular treatments, anti-diabetic agents, nutritional supplements, psychotropic medicines, and specialized preparations for skin, ear, and eye care. Alpa Laboratories distributes its goods through a robust network comprising distributors, retail pharmacies, and hospitals. The company also extends its reach internationally, exporting its products to various regions across South and Central America, Africa, Asia, and the CIS countries.

                  Alpa Laboratories Limited (ALPA) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Bal Pharma Limited
                  ―
                  ―
                  Biofil Chemicals & Pharmaceuticals Ltd.
                  ―
                  ―
                  Brooks Laboratories Limited
                  ―
                  ―
                  Nectar Lifesciences Ltd.
                  ―
                  ―
                  Par Drugs and Chemicals Limited
                  ―
                  ―
                  Popular Stocks